{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=stereotactic+body+radiation+treatments&page=2", "query": { "intervention": "stereotactic body radiation treatments", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 553, "total_pages": 56, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=stereotactic+body+radiation+treatments&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=stereotactic+body+radiation+treatments&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T01:49:03.870Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01497808", "title": "RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastatic Melanoma" ], "interventions": [ { "name": "Ipilimumab", "type": "DRUG" }, { "name": "Stereotactic Body Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Abramson Cancer Center at Penn Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2011-11-29", "completion_date": "2015-10-12", "has_results": true, "last_update_posted_date": "2021-08-10", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01497808" }, { "nct_id": "NCT05939414", "title": "An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Oligometastatic Prostate Cancer (OMPC)" ], "interventions": [ { "name": "AAA617", "type": "DRUG" }, { "name": "piflufolastat (18F)", "type": "DRUG" }, { "name": "gallium (68Ga) gozetotide (25μg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "MALE", "summary": "18 Years to 100 Years · Male only" }, "enrollment_count": 450, "start_date": "2024-03-12", "completion_date": "2031-10-03", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 39, "location_summary": "Fayetteville, Arkansas • Los Angeles, California • Palo Alto, California + 30 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05939414" }, { "nct_id": "NCT07293585", "title": "Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Neurovascular sparing stereotactic body radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 200, "start_date": "2025-12-16", "completion_date": "2036-12-16", "has_results": false, "last_update_posted_date": "2025-12-19", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07293585" }, { "nct_id": "NCT02067858", "title": "An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Non Small Cell Lung Cancer", "4D CT" ], "interventions": [ { "name": "Stereotactic Radiosurgery", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Steven Burton", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2011-04", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2018-07-18", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02067858" }, { "nct_id": "NCT03835533", "title": "Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Metastatic Castration-resistant Prostate Cancer" ], "interventions": [ { "name": "NKTR-214 (Cohort A)", "type": "DRUG" }, { "name": "Nivolumab (Cohort A, B and C)", "type": "DRUG" }, { "name": "Stereotactic body radiation therapy (SBRT) (Cohort B)", "type": "RADIATION" }, { "name": "CDX-301 (Cohort B and C)", "type": "DRUG" }, { "name": "Poly-ICLC (Cohort B)", "type": "DRUG" }, { "name": "INO-5151 (Cohort C)", "type": "DRUG" }, { "name": "Cellectra 2000", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "RADIATION", "DEVICE" ], "sponsor": "Parker Institute for Cancer Immunotherapy", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 43, "start_date": "2019-06-21", "completion_date": "2022-10-03", "has_results": true, "last_update_posted_date": "2024-04-12", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 6, "location_summary": "Los Angeles, California • San Francisco, California • New York, New York + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03835533" }, { "nct_id": "NCT03110978", "title": "Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Atypical Carcinoid Tumor", "Lung Neuroendocrine Neoplasm", "Lung Non-Small Cell Squamous Carcinoma", "Minimally Invasive Lung Adenocarcinoma", "Neuroendocrine Carcinoma", "Recurrent Lung Adenocarcinoma", "Recurrent Lung Large Cell Carcinoma", "Recurrent Lung Non-Small Cell Carcinoma", "Stage I Lung Cancer AJCC v8", "Stage IA1 Lung Cancer AJCC v8", "Stage IA2 Lung Cancer AJCC v8", "Stage IA3 Lung Cancer AJCC v8", "Stage IB Lung Cancer AJCC v8", "Stage IIA Lung Cancer AJCC v8" ], "interventions": [ { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Stereotactic Body Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "RADIATION" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2017-06-26", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-06-22", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 3, "location_summary": "Conroe, Texas • Houston, Texas", "locations": [ { "city": "Conroe", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03110978" }, { "nct_id": "NCT04327986", "title": "Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Histologically or Cytologically Confirmed Pancreatic Cancer", "Unresectable or Borderline Resectable Pancreatic Cancer", "Pancreatic Neoplasms", "Pancreatic Cancer", "Metastatic Pancreatic Cancer" ], "interventions": [ { "name": "M7824", "type": "DRUG" }, { "name": "M9241", "type": "DRUG" }, { "name": "SBRT", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2021-06-15", "completion_date": "2022-02-03", "has_results": true, "last_update_posted_date": "2022-05-18", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04327986" }, { "nct_id": "NCT03559556", "title": "Treating Arteriovenous Malformation With Stereotactic Radiosurgery Using CT Angiography for Treatment Planning", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Arteriovenous Malformations" ], "interventions": [ { "name": "CT angiography", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "10 Years to 120 Years" }, "enrollment_count": 14, "start_date": "2019-07-25", "completion_date": "2024-06-24", "has_results": true, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03559556" }, { "nct_id": "NCT02145286", "title": "Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Metastatic Bone Lesion" ], "interventions": [ { "name": "Stereotactic Body Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Paul W. Read, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2013-10", "completion_date": "2019-01", "has_results": false, "last_update_posted_date": "2018-06-12", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02145286" }, { "nct_id": "NCT02722395", "title": "Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Primary Liver Cancer", "Metastatic Liver Cancer From Any Cancer Site" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 5, "start_date": "2016-08", "completion_date": "2017-02-01", "has_results": false, "last_update_posted_date": "2017-04-06", "last_synced_at": "2026-10-11T01:49:03.870Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02722395" } ] }